Cite
Interleukin-33 signaling exacerbates experimental infectious colitis by enhancing gut permeability and inhibiting protective Th17 immunity
MLA
Alexandra Adamczyk, et al. “Interleukin-33 Signaling Exacerbates Experimental Infectious Colitis by Enhancing Gut Permeability and Inhibiting Protective Th17 Immunity.” Mucosal Immunology, vol. 14, no. 4, Mar. 2021, pp. 923–36. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....68dbdb99843faea00c26242e0621a45c&authtype=sso&custid=ns315887.
APA
Alexandra Adamczyk, Wiebke Hansen, Julia Zöller, Jan Buer, Astrid M. Westendorf, Philippe Krebs, Eva Pastille, Jana-Fabienne Ebel, Christian U. Riedel, Vivian P. Vu, Robert Klopfleisch, Vittoria Palmieri, & Nhi Ngo Thi Phuong. (2021). Interleukin-33 signaling exacerbates experimental infectious colitis by enhancing gut permeability and inhibiting protective Th17 immunity. Mucosal Immunology, 14(4), 923–936.
Chicago
Alexandra Adamczyk, Wiebke Hansen, Julia Zöller, Jan Buer, Astrid M. Westendorf, Philippe Krebs, Eva Pastille, et al. 2021. “Interleukin-33 Signaling Exacerbates Experimental Infectious Colitis by Enhancing Gut Permeability and Inhibiting Protective Th17 Immunity.” Mucosal Immunology 14 (4): 923–36. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....68dbdb99843faea00c26242e0621a45c&authtype=sso&custid=ns315887.